Switch to:
Novo Nordisk A/S (NYSE:NVO)
Cash And Cash Equivalents
$488 Mil (As of Mar. 2014)

Novo Nordisk A/S's quarterly cash and cash equivalents increased from Sep. 2013 ($1,725 Mil) to Dec. 2013 ($2,000 Mil) but then declined from Dec. 2013 ($2,000 Mil) to Mar. 2014 ($488 Mil).

Novo Nordisk A/S's annual cash and cash equivalents declined from Dec. 2011 ($2,328 Mil) to Dec. 2012 ($2,060 Mil) and declined from Dec. 2012 ($2,060 Mil) to Dec. 2013 ($2,000 Mil).


Definition

Cash and cash equivalents on banks book.


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Novo Nordisk A/S Annual Data

Dec04Dec05Dec06Dec07Dec08Dec09Dec10Dec11Dec12Dec13
BS_CashAndCashEquivalents 6105365709541,5642,1652,1562,3282,0602,000

Novo Nordisk A/S Quarterly Data

Dec11Mar12Jun12Sep12Dec12Mar13Jun13Sep13Dec13Mar14
BS_CashAndCashEquivalents 2,3281,4921,4972,3452,0601,2551,4161,7252,000488
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Email Hide